Invasive duct carcinoma of the breast: Copy numbers of CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with the expression of cyclin D1 and estrogen receptor (ERα) detected by immunohistochemistry (IHC);Invazivní duktální karcinomy mléčné žlázy: Vyšetření počtu kopií genu CCND1 a počtu chromozómů 11 metodou fluorescenční in situ hybridizace (FISH) v porovnani s expresi proteinu cyklin D1 a receptoru pro estrogen (ERα) detegovanou imunohistochemicky (IHC)

Casopis Lekaru Ceskych

Volumn 141, Issue 22, 2002, Pages 708-714

  Mrhalová, Marcela ^a   Kodet, R ^a   Strnad, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Amplification; CCND1 gene; Cyclin D1; Estrogen receptor; FISH; Invasive duct carcinoma; Mammary gland

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SIZE; CELL CYCLE; CHROMOSOME 11; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAMMARY GLAND; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 0036915832     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Barnes, D. M., Gillett, C. E.: Cyclin D1 in breast cancer. Breast Cancer Res. Treat., 52, 1998, s. 1-15.
2. Foster, J. S., Henley, D. C., Ahamed, S. et al.: Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab., 12, 2001, s. 320-327.
3. Sutherland, R. L., Hamilton, J. A., Sweeney, K. J. et al.: Expression and regulation of cyclin genes in breast cancer. Acta Oncol., 34, 1995, s. 651-656.
4. Inaba, T., Matsushime, H., Valentine, M. et al.: Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics, 13, 1992, s. 565-574.
5. Hall, M., Peters, G.: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res., 68, 1996, s. 67-108.
6. Frierson, H. F., Jr., Gaffey, M. J., Zukerberg, L. R. et al.: Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod. Pathol., 9, 1996, s. 725-730.
7. Simpson, J. F., Quan, D. E., O'Malley, F. et al.: Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am. J. Pathol., 151, 1997, s. 161-168.
8. Bukholm, I. K., Berner, J. M., Nesland, J. M. et al.: Expression of cyclin Ds in relation to p53 status in human breast carcinomas. Virchows Arch., 433, 1998, s. 223-228.
9. Barbareschi, M., Pelosio, P., Caffo, O. et al.: Cyclin-D1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int. J. Cancer, 74, 1997, s. 171-174.
10. Foster, J. S., Henley, D. C., Bukovsky, A. et al.: Multifaceted regulation of cell cycle progression by estrogen: Regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol. Cell. Biol., 21, 2001, s. 794-810.
11. Neuman, E., Ladha, M. H., Lin, N. et al.: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol., 17, 1997, s. 5338-5347.
12. Wilcken, N. R., Prall, O. W., Musgrove, E. A. et al.: Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin. Cancer Res., 3, 1997, s. 849-854.
13. Mrhalová, M., Kodet, R., Strnad, P.: Korelace exprese c-erbB-2 genu (detekce metodou FISH) s membránovou expresí erbB-2 proteinu (detekce metodou IHC) u pacientek s karcinomy mléčné žlázy. Čas. Lék. Čes., 140, 2001, s. 553-559.
14. Zhang, S. Y., Caamano, J., Cooper, F. et al.: Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol., 102, 1994, s. 695-698.
15. Pelosio, P., Barbareschi, M., Bonoldi, E. et al.: Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann. Oncol., 7, 1996, s. 695-703.
16. Rennstam, K., Baldetorp, B., Kytola, S. et al.: Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer. Cancer Res., 61, 2001, s. 1214-1219.
17. Nielsen, N. H., Emdin, S. O., Cajander, J. et al.: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene, 14, 1997, s. 295-304.
18. Takano, Y., Takenaka, H., Kato, Y. et al.: Cyclin D1 overexpression in invasive breast cancers: Correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity. J. Cancer Res. Clin. Oncol., 125, 1999. s. 505-512.
19. Jares, P., Rey, M. J., Fernandez, P. L. et al.: Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumour proliferation and oestrogen receptor status. J. Pathol., 182, 1997, s. 160-166.
20. Reed, W., Florems, V. A., Holm, R. et al.: Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients. Virchows Arch., 435, 1999, s. 116-124.
21. Gillett, C., Smith, P., Gregory, W. et al.: Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer, 69, 1996, s. 92-99.
22. van Diest, P. J., Michalides, R. J., Jannink, L. et al.: Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am. J. Pathol., 150, 1997, s. 705-711.
23. Hui, R., Cornish, A. L., McClelland, R. A. et al.: Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin. Cancer Res., 2, 1996, s. 923-928.
24. Shoker, B. S., Jarvis, C., Davies, M. P. et al.: Immunodetectable cyclin D(1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br. J. Cancer, 84, 2001, s. 1064-1069.
25. Sabbah, M., Courilleau, D., Mester, J. et al.: Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA, 96, 1999, s. 11217-11222.
26. Lin, S. Y., Xia, W., Wang, J. C. et al.: Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. USA, 97, 2000, s. 4262-4266.
27. Planas-Silva, M. D., Shang, Y., Donaher, J. L. et al.: AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res., 61, 2001, s. 3858-3862.
28. Wintersberger, E.: DNA amplification: new insights into its mechanism. Chromosoma, 103, 1994, s. 73-81.
29. Srimatkandada, S., Dube, S. K., Carmen, M. et al.: Coamplification of 3-hydroxy-3-methylglutaryl coenzyme A reductase genes in methotrexate-resistant human leukemia cell lines. Oncol. Res., 12, 2000, s. 11-15.
30. Sauter, G., Feichter, G., Torhorst, J. et al.: Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol., 40, 1996, s. 164-173.
31. Ooi, A., Kobayashi, M., Mai, M. et al.: Amplification of c-erbB-2 in gastric cancer: Detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. Lab. Invest., 78, 1998, s. 345-351.
32. Zwijsen, R. M., Wientjens, E., Klompmaker, R. et al.: CDK-independent activation of estrogen receptor by cyclin D1. Cell, 88, 1997, s. 405-415.
33. Yu, Q., Geng, Y., Sicinski, P.: Specific protection against breast cancers by cyclin D1 ablation. Nature, 411, 2001, s. 1017-1021.